Correlation Between Mosaic Immunoengineerin and Oncotelic Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mosaic Immunoengineerin and Oncotelic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mosaic Immunoengineerin and Oncotelic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mosaic Immunoengineering and Oncotelic Therapeutics, you can compare the effects of market volatilities on Mosaic Immunoengineerin and Oncotelic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mosaic Immunoengineerin with a short position of Oncotelic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mosaic Immunoengineerin and Oncotelic Therapeutics.

Diversification Opportunities for Mosaic Immunoengineerin and Oncotelic Therapeutics

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Mosaic and Oncotelic is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Mosaic Immunoengineering and Oncotelic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncotelic Therapeutics and Mosaic Immunoengineerin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mosaic Immunoengineering are associated (or correlated) with Oncotelic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncotelic Therapeutics has no effect on the direction of Mosaic Immunoengineerin i.e., Mosaic Immunoengineerin and Oncotelic Therapeutics go up and down completely randomly.

Pair Corralation between Mosaic Immunoengineerin and Oncotelic Therapeutics

If you would invest  51.00  in Mosaic Immunoengineering on September 2, 2024 and sell it today you would earn a total of  49.00  from holding Mosaic Immunoengineering or generate 96.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy0.4%
ValuesDaily Returns

Mosaic Immunoengineering  vs.  Oncotelic Therapeutics

 Performance 
       Timeline  
Mosaic Immunoengineering 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mosaic Immunoengineering are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Mosaic Immunoengineerin showed solid returns over the last few months and may actually be approaching a breakup point.
Oncotelic Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncotelic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Oncotelic Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Mosaic Immunoengineerin and Oncotelic Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mosaic Immunoengineerin and Oncotelic Therapeutics

The main advantage of trading using opposite Mosaic Immunoengineerin and Oncotelic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mosaic Immunoengineerin position performs unexpectedly, Oncotelic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncotelic Therapeutics will offset losses from the drop in Oncotelic Therapeutics' long position.
The idea behind Mosaic Immunoengineering and Oncotelic Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity